APO Research
Talk to an analyst

APO RESEARCH · REPORT

Desloratadine Oral Solution

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Desloratadine Oral Solution Industry Growth and Trends Forecast to 2032

20 December 2025105 pages

Choose your research edition.

Industry ResearchDesloratadine Oral Solution Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Desloratadine Oral Solution Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Desloratadine Oral Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Desloratadine Oral Solution Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Desloratadine Oral Solution Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Desloratadine Oral Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Desloratadine Oral Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Desloratadine Oral Solution is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Desloratadine Oral Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Desloratadine Oral Solution include Yabao Pharmaceutical, SHIJIAZHUANG HUAXIN PHARMACEUTICAL, Shandong Langnuo Pharmaceutical, Merck Sharp & Dohme, Huluwa Pharmaceutical, Hefei Amvite Pharmaceutical, Harbin Sanctity Biological Pharmaceutical, Sinopharm Zhijun and Beimei Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Desloratadine Oral Solution market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Desloratadine Oral Solution market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Desloratadine Oral Solution market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Desloratadine Oral Solution.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Desloratadine Oral Solution market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Desloratadine Oral Solution Market by Company

Yabao Pharmaceutical

SHIJIAZHUANG HUAXIN PHARMACEUTICAL

Shandong Langnuo Pharmaceutical

Merck Sharp & Dohme

Huluwa Pharmaceutical

Hefei Amvite Pharmaceutical

Harbin Sanctity Biological Pharmaceutical

Sinopharm Zhijun

Beimei Pharmaceutical

Avanc Pharma

Anhui Xinshiji Pharmaceutical

Desloratadine Oral Solution Segment by Type

0.5mg/ml

0.25mg/ml

Desloratadine Oral Solution Segment by Application

Hospital

Clinic

Pharmacy

Desloratadine Oral Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Desloratadine Oral Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Desloratadine Oral Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Desloratadine Oral Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Desloratadine Oral Solution manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Desloratadine Oral Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.5mg/ml Table 2. Major Company of 0.25mg/ml Table 3. Global Desloratadine Oral Solution Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Desloratadine Oral Solution Sales by Type (2021-2026) & (k units) Table 5. Global Desloratadine Oral Solution Sales Market Share in Volume by Type (2021-2026) Table 6. Global Desloratadine Oral Solution Sales by Type (2021-2026) & (US$ Million) Table 7. Global Desloratadine Oral Solution Sales Market Share in Value by Type (2021-2026) Table 8. Global Desloratadine Oral Solution Price by Type (2021-2026) & (US$/unit) Table 9. Global Desloratadine Oral Solution Sales by Type (2027-2032) & (k units) Table 10. Global Desloratadine Oral Solution Sales Market Share in Volume by Type (2027-2032) Table 11. Global Desloratadine Oral Solution Sales by Type (2027-2032) & (US$ Million) Table 12. Global Desloratadine Oral Solution Sales Market Share in Value by Type (2027-2032) Table 13. Global Desloratadine Oral Solution Price by Type (2027-2032) & (US$/unit) Table 14. North America Desloratadine Oral Solution Sales by Type (2021-2026) & (k units) Table 15. North America Desloratadine Oral Solution Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Desloratadine Oral Solution Sales by Type (2021-2026) & (k units) Table 17. Europe Desloratadine Oral Solution Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Desloratadine Oral Solution Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Desloratadine Oral Solution Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Desloratadine Oral Solution Sales by Type (2021-2026) & (k units) Table 21. Latin America Desloratadine Oral Solution Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Desloratadine Oral Solution Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Desloratadine Oral Solution Sales by Type (2021-2026) & (US$ Million) Table 24. Desloratadine Oral Solution Industry Trends Table 25. Desloratadine Oral Solution Industry Drivers Table 26. Desloratadine Oral Solution Industry Opportunities and Challenges Table 27. Desloratadine Oral Solution Industry Restraints Table 28. Global Desloratadine Oral Solution Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Desloratadine Oral Solution Revenue Market Share by Company (2021-2026) Table 30. Global Desloratadine Oral Solution Sales by Company (2021-2026) & (k units) Table 31. Global Desloratadine Oral Solution Sales Share by Company (2021-2026) Table 32. Global Desloratadine Oral Solution Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Desloratadine Oral Solution Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Desloratadine Oral Solution Major Company Production Sites and Headquarters Table 35. Global Desloratadine Oral Solution Company, Product Type & Application Table 36. Global Desloratadine Oral Solution Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Desloratadine Oral Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Desloratadine Oral Solution Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Desloratadine Oral Solution Sales by Region (2021-2026) & (k units) Table 41. Global Desloratadine Oral Solution Sales Market Share in Volume by Region (2021-2026) Table 42. Global Desloratadine Oral Solution Sales by Region (2021-2026) & (US$ Million) Table 43. Global Desloratadine Oral Solution Sales Market Share in Value by Region (2021-2026) Table 44. Global Desloratadine Oral Solution Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Desloratadine Oral Solution Sales by Region (2027-2032) & (k units) Table 46. Global Desloratadine Oral Solution Sales Market Share in Volume by Region (2027-2032) Table 47. Global Desloratadine Oral Solution Sales by Region (2027-2032) & (US$ Million) Table 48. Global Desloratadine Oral Solution Sales Market Share in Value by Region (2027-2032) Table 49. Global Desloratadine Oral Solution Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Desloratadine Oral Solution Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Desloratadine Oral Solution Sales by Application (2021-2026) & (k units) Table 52. Global Desloratadine Oral Solution Sales Market Share in Volume by Application (2021-2026) Table 53. Global Desloratadine Oral Solution Sales by Application (2021-2026) & (US$ Million) Table 54. Global Desloratadine Oral Solution Sales Market Share in Value by Application (2021-2026) Table 55. Global Desloratadine Oral Solution Price by Application (2021-2026) & (US$/unit) Table 56. Global Desloratadine Oral Solution Sales by Application (2027-2032) & (k units) Table 57. Global Desloratadine Oral Solution Sales Market Share in Volume by Application (2027-2032) Table 58. Global Desloratadine Oral Solution Sales by Application (2027-2032) & (US$ Million) Table 59. Global Desloratadine Oral Solution Sales Market Share in Value by Application (2027-2032) Table 60. Global Desloratadine Oral Solution Price by Application (2027-2032) & (US$/unit) Table 61. North America Desloratadine Oral Solution Sales by Application (2021-2026) & (k units) Table 62. North America Desloratadine Oral Solution Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Desloratadine Oral Solution Sales by Application (2021-2026) & (k units) Table 64. Europe Desloratadine Oral Solution Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Desloratadine Oral Solution Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Desloratadine Oral Solution Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Desloratadine Oral Solution Sales by Application (2021-2026) & (k units) Table 68. Latin America Desloratadine Oral Solution Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Desloratadine Oral Solution Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Desloratadine Oral Solution Sales by Application (2021-2026) & (US$ Million) Table 71. Yabao Pharmaceutical Company Information Table 72. Yabao Pharmaceutical Business Overview Table 73. Yabao Pharmaceutical Desloratadine Oral Solution Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Yabao Pharmaceutical Desloratadine Oral Solution Product Portfolio Table 75. Yabao Pharmaceutical Recent Development Table 76. SHIJIAZHUANG HUAXIN PHARMACEUTICAL Company Information Table 77. SHIJIAZHUANG HUAXIN PHARMACEUTICAL Business Overview Table 78. SHIJIAZHUANG HUAXIN PHARMACEUTICAL Desloratadine Oral Solution Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. SHIJIAZHUANG HUAXIN PHARMACEUTICAL Desloratadine Oral Solution Product Portfolio Table 80. SHIJIAZHUANG HUAXIN PHARMACEUTICAL Recent Development Table 81. Shandong Langnuo Pharmaceutical Company Information Table 82. Shandong Langnuo Pharmaceutical Business Overview Table 83. Shandong Langnuo Pharmaceutical Desloratadine Oral Solution Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Shandong Langnuo Pharmaceutical Desloratadine Oral Solution Product Portfolio Table 85. Shandong Langnuo Pharmaceutical Recent Development Table 86. Merck Sharp & Dohme Company Information Table 87. Merck Sharp & Dohme Business Overview Table 88. Merck Sharp & Dohme Desloratadine Oral Solution Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Merck Sharp & Dohme Desloratadine Oral Solution Product Portfolio Table 90. Merck Sharp & Dohme Recent Development Table 91. Huluwa Pharmaceutical Company Information Table 92. Huluwa Pharmaceutical Business Overview Table 93. Huluwa Pharmaceutical Desloratadine Oral Solution Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Huluwa Pharmaceutical Desloratadine Oral Solution Product Portfolio Table 95. Huluwa Pharmaceutical Recent Development Table 96. Hefei Amvite Pharmaceutical Company Information Table 97. Hefei Amvite Pharmaceutical Business Overview Table 98. Hefei Amvite Pharmaceutical Desloratadine Oral Solution Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Hefei Amvite Pharmaceutical Desloratadine Oral Solution Product Portfolio Table 100. Hefei Amvite Pharmaceutical Recent Development Table 101. Harbin Sanctity Biological Pharmaceutical Company Information Table 102. Harbin Sanctity Biological Pharmaceutical Business Overview Table 103. Harbin Sanctity Biological Pharmaceutical Desloratadine Oral Solution Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Harbin Sanctity Biological Pharmaceutical Desloratadine Oral Solution Product Portfolio Table 105. Harbin Sanctity Biological Pharmaceutical Recent Development Table 106. Sinopharm Zhijun Company Information Table 107. Sinopharm Zhijun Business Overview Table 108. Sinopharm Zhijun Desloratadine Oral Solution Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Sinopharm Zhijun Desloratadine Oral Solution Product Portfolio Table 110. Sinopharm Zhijun Recent Development Table 111. Beimei Pharmaceutical Company Information Table 112. Beimei Pharmaceutical Business Overview Table 113. Beimei Pharmaceutical Desloratadine Oral Solution Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Beimei Pharmaceutical Desloratadine Oral Solution Product Portfolio Table 115. Beimei Pharmaceutical Recent Development Table 116. Avanc Pharma Company Information Table 117. Avanc Pharma Business Overview Table 118. Avanc Pharma Desloratadine Oral Solution Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Avanc Pharma Desloratadine Oral Solution Product Portfolio Table 120. Avanc Pharma Recent Development Table 121. Anhui Xinshiji Pharmaceutical Company Information Table 122. Anhui Xinshiji Pharmaceutical Business Overview Table 123. Anhui Xinshiji Pharmaceutical Desloratadine Oral Solution Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Anhui Xinshiji Pharmaceutical Desloratadine Oral Solution Product Portfolio Table 125. Anhui Xinshiji Pharmaceutical Recent Development Table 126. North America Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. North America Desloratadine Oral Solution Sales by Country (2021-2026) & (k units) Table 128. North America Desloratadine Oral Solution Sales Market Share by Country (2021-2026) Table 129. North America Desloratadine Oral Solution Sales Forecast by Country (2027-2032) & (k units) Table 130. North America Desloratadine Oral Solution Sales Market Share Forecast by Country (2027-2032) Table 131. North America Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Desloratadine Oral Solution Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Desloratadine Oral Solution Market Share by Country (2021-2026) Table 134. North America Desloratadine Oral Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Desloratadine Oral Solution Market Share Forecast by Country (2027-2032) Table 136. Europe Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Europe Desloratadine Oral Solution Sales by Country (2021-2026) & (k units) Table 138. Europe Desloratadine Oral Solution Sales Market Share by Country (2021-2026) Table 139. Europe Desloratadine Oral Solution Sales Forecast by Country (2027-2032) & (k units) Table 140. Europe Desloratadine Oral Solution Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Desloratadine Oral Solution Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Desloratadine Oral Solution Market Share by Country (2021-2026) Table 144. Europe Desloratadine Oral Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Desloratadine Oral Solution Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Desloratadine Oral Solution Sales by Country (2021-2026) & (k units) Table 148. Asia-Pacific Desloratadine Oral Solution Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Desloratadine Oral Solution Sales Forecast by Country (2027-2032) & (k units) Table 150. Asia-Pacific Desloratadine Oral Solution Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Desloratadine Oral Solution Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Desloratadine Oral Solution Market Share by Country (2021-2026) Table 154. Asia-Pacific Desloratadine Oral Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Desloratadine Oral Solution Market Share Forecast by Country (2027-2032) Table 156. Latin America Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Latin America Desloratadine Oral Solution Sales by Country (2021-2026) & (k units) Table 158. Latin America Desloratadine Oral Solution Sales Market Share by Country (2021-2026) Table 159. Latin America Desloratadine Oral Solution Sales Forecast by Country (2027-2032) & (k units) Table 160. Latin America Desloratadine Oral Solution Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Desloratadine Oral Solution Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Desloratadine Oral Solution Market Share by Country (2021-2026) Table 164. Latin America Desloratadine Oral Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Desloratadine Oral Solution Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Desloratadine Oral Solution Sales by Country (2021-2026) & (k units) Table 168. Middle East and Africa Desloratadine Oral Solution Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Desloratadine Oral Solution Sales Forecast by Country (2027-2032) & (k units) Table 170. Middle East and Africa Desloratadine Oral Solution Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Desloratadine Oral Solution Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Desloratadine Oral Solution Market Share by Country (2021-2026) Table 174. Middle East and Africa Desloratadine Oral Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Desloratadine Oral Solution Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Desloratadine Oral Solution Distributors List Table 179. Desloratadine Oral Solution Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Desloratadine Oral Solution Image Figure 2. Global Desloratadine Oral Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Desloratadine Oral Solution Market Size (2021-2032) & (US$ Million) Figure 4. Global Desloratadine Oral Solution Sales (2021-2032) & (k units) Figure 5. 0.5mg/ml Image Figure 6. Global 0.5mg/ml Sales YoY Growth (2021-2032) & (k units) Figure 7. 0.25mg/ml Image Figure 8. Global 0.25mg/ml Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Desloratadine Oral Solution Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Desloratadine Oral Solution Market Share by Type 2025 VS 2032 Figure 11. North America Desloratadine Oral Solution Sales Market Share in Volume by Type in 2025 Figure 12. North America Desloratadine Oral Solution Sales Market Share in Value by Type in 2025 Figure 13. Europe Desloratadine Oral Solution Sales Market Share in Volume by Type in 2025 Figure 14. Europe Desloratadine Oral Solution Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Desloratadine Oral Solution Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Desloratadine Oral Solution Sales Market Share in Value by Type in 2025 Figure 17. Latin America Desloratadine Oral Solution Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Desloratadine Oral Solution Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Desloratadine Oral Solution Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Desloratadine Oral Solution Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Desloratadine Oral Solution Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Desloratadine Oral Solution Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Desloratadine Oral Solution Market Share by Application 2025 VS 2032 Figure 31. North America Desloratadine Oral Solution Sales Market Share in Volume by Application in 2025 Figure 32. North America Desloratadine Oral Solution Sales Market Share in Value by Application in 2025 Figure 33. Europe Desloratadine Oral Solution Sales Market Share in Volume by Application in 2025 Figure 34. Europe Desloratadine Oral Solution Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Desloratadine Oral Solution Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Desloratadine Oral Solution Sales Market Share in Value by Application in 2025 Figure 37. Latin America Desloratadine Oral Solution Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Desloratadine Oral Solution Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Desloratadine Oral Solution Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Desloratadine Oral Solution Sales Market Share in Value by Application in 2025 Figure 41. North America Desloratadine Oral Solution Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Desloratadine Oral Solution Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Desloratadine Oral Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Desloratadine Oral Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Desloratadine Oral Solution Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Desloratadine Oral Solution Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Desloratadine Oral Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Desloratadine Oral Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Desloratadine Oral Solution Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Desloratadine Oral Solution Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Desloratadine Oral Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Desloratadine Oral Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Desloratadine Oral Solution Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Desloratadine Oral Solution Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Desloratadine Oral Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Desloratadine Oral Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Desloratadine Oral Solution Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Desloratadine Oral Solution Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Desloratadine Oral Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Desloratadine Oral Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Desloratadine Oral Solution Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Desloratadine Oral Solution Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5mg/ml
  • 0.25mg/ml
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • Yabao Pharmaceutical
  • SHIJIAZHUANG HUAXIN PHARMACEUTICAL
  • Shandong Langnuo Pharmaceutical
  • Merck Sharp & Dohme
  • Huluwa Pharmaceutical
  • Hefei Amvite Pharmaceutical
  • Harbin Sanctity Biological Pharmaceutical
  • Sinopharm Zhijun
  • Beimei Pharmaceutical
  • Avanc Pharma
  • Anhui Xinshiji Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Desloratadine Oral Solution Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Desloratadine Oral Solution Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Desloratadine Oral Solution Market by Type
  6. 1.3.1 0.5mg/ml
  7. 1.3.2 0.25mg/ml
  8. 1.4 Global Desloratadine Oral Solution Market Size by Type
  9. 1.4.1 Global Desloratadine Oral Solution Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Desloratadine Oral Solution Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Desloratadine Oral Solution Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Desloratadine Oral Solution Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Desloratadine Oral Solution Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Desloratadine Oral Solution Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Desloratadine Oral Solution Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Desloratadine Oral Solution Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Desloratadine Oral Solution Industry Trends
  2. 2.2 Desloratadine Oral Solution Industry Drivers
  3. 2.3 Desloratadine Oral Solution Industry Opportunities and Challenges
  4. 2.4 Desloratadine Oral Solution Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Desloratadine Oral Solution Revenue (2021-2026)
  2. 3.2 Global Top Players by Desloratadine Oral Solution Sales (2021-2026)
  3. 3.3 Global Top Players by Desloratadine Oral Solution Price (2021-2026)
  4. 3.4 Global Desloratadine Oral Solution Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Desloratadine Oral Solution Major Company Production Sites & Headquarters
  6. 3.6 Global Desloratadine Oral Solution Company, Product Type & Application
  7. 3.7 Global Desloratadine Oral Solution Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Desloratadine Oral Solution Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Desloratadine Oral Solution Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Desloratadine Oral Solution Tier 1, Tier 2, and Tier 3
4 Desloratadine Oral Solution Regional Status and Outlook
  1. 4.1 Global Desloratadine Oral Solution Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Desloratadine Oral Solution Historic Market Size by Region
  3. 4.2.1 Global Desloratadine Oral Solution Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Desloratadine Oral Solution Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Desloratadine Oral Solution Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Desloratadine Oral Solution Forecasted Market Size by Region
  7. 4.3.1 Global Desloratadine Oral Solution Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Desloratadine Oral Solution Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Desloratadine Oral Solution Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Desloratadine Oral Solution by Application
  1. 5.1 Desloratadine Oral Solution Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global Desloratadine Oral Solution Market Size by Application
  6. 5.2.1 Global Desloratadine Oral Solution Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Desloratadine Oral Solution Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Desloratadine Oral Solution Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Desloratadine Oral Solution Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Desloratadine Oral Solution Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Desloratadine Oral Solution Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Desloratadine Oral Solution Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Desloratadine Oral Solution Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yabao Pharmaceutical
  2. 6.1.1 Yabao Pharmaceutical Company Information
  3. 6.1.2 Yabao Pharmaceutical Business Overview
  4. 6.1.3 Yabao Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yabao Pharmaceutical Desloratadine Oral Solution Product Portfolio
  6. 6.1.5 Yabao Pharmaceutical Recent Developments
  7. 6.2 SHIJIAZHUANG HUAXIN PHARMACEUTICAL
  8. 6.2.1 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Company Information
  9. 6.2.2 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Business Overview
  10. 6.2.3 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Desloratadine Oral Solution Product Portfolio
  12. 6.2.5 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Recent Developments
  13. 6.3 Shandong Langnuo Pharmaceutical
  14. 6.3.1 Shandong Langnuo Pharmaceutical Company Information
  15. 6.3.2 Shandong Langnuo Pharmaceutical Business Overview
  16. 6.3.3 Shandong Langnuo Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shandong Langnuo Pharmaceutical Desloratadine Oral Solution Product Portfolio
  18. 6.3.5 Shandong Langnuo Pharmaceutical Recent Developments
  19. 6.4 Merck Sharp & Dohme
  20. 6.4.1 Merck Sharp & Dohme Company Information
  21. 6.4.2 Merck Sharp & Dohme Business Overview
  22. 6.4.3 Merck Sharp & Dohme Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Sharp & Dohme Desloratadine Oral Solution Product Portfolio
  24. 6.4.5 Merck Sharp & Dohme Recent Developments
  25. 6.5 Huluwa Pharmaceutical
  26. 6.5.1 Huluwa Pharmaceutical Company Information
  27. 6.5.2 Huluwa Pharmaceutical Business Overview
  28. 6.5.3 Huluwa Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Huluwa Pharmaceutical Desloratadine Oral Solution Product Portfolio
  30. 6.5.5 Huluwa Pharmaceutical Recent Developments
  31. 6.6 Hefei Amvite Pharmaceutical
  32. 6.6.1 Hefei Amvite Pharmaceutical Company Information
  33. 6.6.2 Hefei Amvite Pharmaceutical Business Overview
  34. 6.6.3 Hefei Amvite Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hefei Amvite Pharmaceutical Desloratadine Oral Solution Product Portfolio
  36. 6.6.5 Hefei Amvite Pharmaceutical Recent Developments
  37. 6.7 Harbin Sanctity Biological Pharmaceutical
  38. 6.7.1 Harbin Sanctity Biological Pharmaceutical Company Information
  39. 6.7.2 Harbin Sanctity Biological Pharmaceutical Business Overview
  40. 6.7.3 Harbin Sanctity Biological Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Harbin Sanctity Biological Pharmaceutical Desloratadine Oral Solution Product Portfolio
  42. 6.7.5 Harbin Sanctity Biological Pharmaceutical Recent Developments
  43. 6.8 Sinopharm Zhijun
  44. 6.8.1 Sinopharm Zhijun Company Information
  45. 6.8.2 Sinopharm Zhijun Business Overview
  46. 6.8.3 Sinopharm Zhijun Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sinopharm Zhijun Desloratadine Oral Solution Product Portfolio
  48. 6.8.5 Sinopharm Zhijun Recent Developments
  49. 6.9 Beimei Pharmaceutical
  50. 6.9.1 Beimei Pharmaceutical Company Information
  51. 6.9.2 Beimei Pharmaceutical Business Overview
  52. 6.9.3 Beimei Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Beimei Pharmaceutical Desloratadine Oral Solution Product Portfolio
  54. 6.9.5 Beimei Pharmaceutical Recent Developments
  55. 6.10 Avanc Pharma
  56. 6.10.1 Avanc Pharma Company Information
  57. 6.10.2 Avanc Pharma Business Overview
  58. 6.10.3 Avanc Pharma Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Avanc Pharma Desloratadine Oral Solution Product Portfolio
  60. 6.10.5 Avanc Pharma Recent Developments
  61. 6.11 Anhui Xinshiji Pharmaceutical
  62. 6.11.1 Anhui Xinshiji Pharmaceutical Company Information
  63. 6.11.2 Anhui Xinshiji Pharmaceutical Business Overview
  64. 6.11.3 Anhui Xinshiji Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Anhui Xinshiji Pharmaceutical Desloratadine Oral Solution Product Portfolio
  66. 6.11.5 Anhui Xinshiji Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Desloratadine Oral Solution Sales by Country
  2. 7.1.1 North America Desloratadine Oral Solution Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Desloratadine Oral Solution Sales by Country (2021-2026)
  4. 7.1.3 North America Desloratadine Oral Solution Sales Forecast by Country (2027-2032)
  5. 7.2 North America Desloratadine Oral Solution Market Size by Country
  6. 7.2.1 North America Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Desloratadine Oral Solution Market Size by Country (2021-2026)
  8. 7.2.3 North America Desloratadine Oral Solution Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Desloratadine Oral Solution Sales by Country
  2. 8.1.1 Europe Desloratadine Oral Solution Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Desloratadine Oral Solution Sales by Country (2021-2026)
  4. 8.1.3 Europe Desloratadine Oral Solution Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Desloratadine Oral Solution Market Size by Country
  6. 8.2.1 Europe Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Desloratadine Oral Solution Market Size by Country (2021-2026)
  8. 8.2.3 Europe Desloratadine Oral Solution Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Desloratadine Oral Solution Sales by Country
  2. 9.1.1 Asia-Pacific Desloratadine Oral Solution Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Desloratadine Oral Solution Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Desloratadine Oral Solution Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Desloratadine Oral Solution Market Size by Country
  6. 9.2.1 Asia-Pacific Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Desloratadine Oral Solution Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Desloratadine Oral Solution Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Desloratadine Oral Solution Sales by Country
  2. 10.1.1 South America Desloratadine Oral Solution Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Desloratadine Oral Solution Sales by Country (2021-2026)
  4. 10.1.3 South America Desloratadine Oral Solution Sales Forecast by Country (2027-2032)
  5. 10.2 South America Desloratadine Oral Solution Market Size by Country
  6. 10.2.1 South America Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Desloratadine Oral Solution Market Size by Country (2021-2026)
  8. 10.2.3 South America Desloratadine Oral Solution Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Desloratadine Oral Solution Sales by Country
  2. 11.1.1 Middle East and Africa Desloratadine Oral Solution Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Desloratadine Oral Solution Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Desloratadine Oral Solution Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Desloratadine Oral Solution Market Size by Country
  6. 11.2.1 Middle East and Africa Desloratadine Oral Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Desloratadine Oral Solution Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Desloratadine Oral Solution Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Desloratadine Oral Solution Value Chain Analysis
  2. 12.1.1 Desloratadine Oral Solution Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Desloratadine Oral Solution Production Mode & Process
  7. 12.2 Desloratadine Oral Solution Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Desloratadine Oral Solution Distributors
  10. 12.2.3 Desloratadine Oral Solution Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst